CapsoVision raises $14 million in private placement financing

CapsoVision Inc. (NASDAQ: CV) completed a $14 million private placement financing on March 16, according to a company statement.

The medical technology company sold 2,867,089 shares of common stock at $4.883 per share to accredited investors. The price represents a 5% discount to the March 16 closing price. The Benchmark Company, LLC and Roth Capital Partners served as financial advisors for the transaction.

CapsoVision plans to use the net proceeds for general corporate purposes, including sales and marketing, research and development activities, and working capital needs.

"The participation of both new and existing investors in this financing underscores confidence in our platform and long-term opportunity," said Johnny Wang, President and Chief Executive Officer. "We intend to deploy the proceeds toward continued product innovation and advancement of our pipeline, including CapsoCam Colon, CapsoCam UGI, and enhanced AI capabilities."

The company also reported preliminary financial results for 2025. Fourth quarter revenue reached $3.9 million, while full year revenue totaled $13.6 million. As of December 31, 2025, CapsoVision held approximately $10.1 million in cash, cash equivalents, restricted cash and investments.

The shares were sold in a private transaction not registered under the Securities Act of 1933. CapsoVision agreed to file a registration statement with the SEC covering the resale of the shares within 90 days after closing.

CapsoVision develops capsule endoscopy solutions for gastrointestinal disease detection. Its flagship product is CapsoCam Plus, a wireless panoramic capsule endoscope for small bowel visualization.

The company will release complete fourth quarter and full year 2025 financial results on March 26.

You May Also Be Interested In

• AMC Entertainment prices $200M stock offering to redeem senior notes
• Creatd files Form S-1 and reports Q1 2026 financial results
• Energy Fuels to acquire rare earth magnet maker VAC for $1.9 billion